Lisata Therapeutics
LSTA

Lisata Therapeutics (LSTA) analyst forecast and price target

Analyst forecast

Hold

Consensus of 1 analyst rating

Buy
0
Hold
1
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.DowngradedBuy → NeutralMay 15, 2026
Brookline CapitalDowngradedBuy → HoldJan 21, 2026
HC Wainwright & Co.MaintainedBuy$15.00Aug 21, 2025
Brookline CapitalMaintainedBuy$32.00 from $20.00Jul 15, 2025
HC Wainwright & Co.MaintainedBuy$15.00Dec 11, 2024
HC Wainwright & Co.MaintainedBuy$15.00Nov 21, 2024
HC Wainwright & Co.MaintainedBuy$15.00Sep 18, 2024
HC Wainwright & Co.MaintainedBuy$15.00Aug 13, 2024
HC Wainwright & Co.MaintainedBuy$15.00Jul 19, 2024
HC Wainwright & Co.MaintainedBuy$15.00Jul 10, 2024
HC Wainwright & Co.MaintainedBuy$15.00Jun 14, 2024
HC Wainwright & Co.MaintainedBuy$15.00May 21, 2024
HC Wainwright & Co.MaintainedBuy$15.00Apr 26, 2024
HC Wainwright & Co.MaintainedBuy$15.00Apr 25, 2024
HC Wainwright & Co.MaintainedBuy$15.00Mar 1, 2024
HC Wainwright & Co.MaintainedBuy$15.00Jan 4, 2024
HC Wainwright & Co.MaintainedBuy$15.00Aug 15, 2023
HC Wainwright & Co.MaintainedBuy$15.00May 25, 2023
HC Wainwright & Co.MaintainedBuy$15.00Mar 31, 2023

Frequently asked questions

  • Is LSTA a buy, sell, or hold?

    Analysts covering Lisata Therapeutics currently average a Hold rating: 0 buy, 1 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on LSTA?

    On May 15, 2026, HC Wainwright & Co. downgraded Lisata Therapeutics to Neutral.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.